Data / Drug companies / Amoxicillin
Amoxicillin: 35 companies and 278 products in the FDA NDC directory
Amoxicillin is listed in the FDA National Drug Code Directory by 35 companies, with 278 products in commercial distribution. 274 of the products (98.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; powder, for suspension; tablet, film coated, and the newest product started marketing on September 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 35
- Products
- 278
- Generic (ANDA) products
- 274 (98.6%)
- Application numbers
- 23
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list amoxicillin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 45 | powder, for suspension; capsule | Generic drugs (ANDA) | September 15, 2014 |
| NuCare Pharmaceuticals,Inc. | 38 | capsule; powder, for suspension | Generic drugs (ANDA) | April 1, 2024 |
| Preferred Pharmaceuticals Inc. | 16 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | July 15, 2026 |
| Chartwell RX, LLC | 15 | powder, for suspension; capsule | Generic drugs (ANDA) | June 18, 2007 |
| Remedyrepack Inc. | 15 | capsule; tablet, film coated | Generic drugs (ANDA) | December 2, 2025 |
| Asclemed USA, Inc. | 12 | capsule; powder, for suspension | Generic drugs (ANDA) | December 12, 2017 |
| Bryant Ranch Prepack | 12 | capsule; tablet, film coated | Generic drugs (ANDA) | November 9, 2005 |
| Proficient Rx LP | 11 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | March 26, 2007 |
| Teva Pharmaceuticals USA, Inc. | 9 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | April 2, 2003 |
| Aurobindo Pharma Limited | 8 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | September 15, 2014 |
| Proficient Rx LP | 8 | powder, for suspension; capsule | Generic drugs (ANDA) | March 26, 2007 |
| Sandoz Inc | 8 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | March 26, 2007 |
| Redpharm Drug | 7 | capsule; tablet, coated | Generic drugs (ANDA) | September 15, 2022 |
| Hikma Pharmaceuticals USA Inc. | 6 | powder, for suspension; tablet, coated | Generic drugs (ANDA) | March 1, 2007 |
| Rising Pharma Holdings, Inc. | 6 | tablet, film coated; capsule | Generic drugs (ANDA) | December 28, 2006 |
| Coupler LLC | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | August 3, 2026 |
| Hawaii Repack, Inc. | 5 | powder, for suspension; capsule | Generic drugs (ANDA) | March 26, 2007 |
| PD-Rx Pharmaceuticals, Inc. | 5 | capsule; tablet, coated | Generic drugs (ANDA) | March 29, 2006 |
| QPharma, Inc. | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | November 9, 2005 |
| Sportpharm LLC | 5 | capsule | Generic drugs (ANDA) | August 16, 2023 |
| American Health Packaging | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | March 25, 2025 |
| Northwind Health Company, LLC | 4 | capsule; tablet, chewable | Generic drugs (ANDA) | September 15, 2026 |
| NuCare Pharmaceuticals, Inc. | 4 | tablet, chewable; powder, for suspension | Generic drugs (ANDA) | June 19, 2006 |
| PD-Rx Pharmaceuticals, Inc. | 4 | capsule; tablet, coated | Generic drugs (ANDA) | March 1, 2007 |
| USAntibiotics, LLC | 4 | capsule; for suspension | Generic drugs (ANDA) | May 15, 2025 |
| Chartwell Governmental & Specialty RX, LLC. | 3 | capsule | Generic drugs (ANDA) | September 30, 1990 |
| Proficient Rx LP | 3 | capsule; powder, for suspension | Generic drugs (ANDA) | November 1, 2022 |
| Direct_Rx | 2 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | April 17, 2023 |
| Micro Labs Limited | 2 | capsule | Generic drugs (ANDA) | November 1, 2022 |
| NorthStar Rx LLC | 2 | capsule | Generic drugs (ANDA) | November 9, 2005 |
| Advanced Rx of Tennessee, LLC | 1 | capsule | Generic drugs (ANDA) | February 15, 2023 |
| Asclemed USA Inc. | 1 | for suspension | Authorized generics (NDA) | April 1, 2024 |
| Direct RX | 1 | powder, for suspension | Generic drugs (ANDA) | January 1, 2014 |
| Health Department, Oklahoma State | 1 | capsule | Generic drugs (ANDA) | November 9, 2005 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, chewable | Generic drugs (ANDA) | January 1, 1993 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 123 | 44.2% |
| Powder, for suspension | 89 | 32% |
| Tablet, film coated | 40 | 14.4% |
| Tablet, chewable | 12 | 4.3% |
| Tablet, coated | 10 | 3.6% |
| For suspension | 4 | 1.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 274 | 98.6% |
| Authorized generics (NDA) | 4 | 1.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Penicillin-class Antibacterial | 278 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.